oprD, gyrA 및 parC 유전자에 변이를 갖는 Carbapenem 내성 녹농균
Chromosomal Mutations in oprD, gyrA, and parC in Carbapenem Resistant Pseudomonas aeruginosa
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
배경: Carbapenem 내성 녹농균의 확산은 이 균에 의한 감염증 치료에 많은 어려움을 준다. 본 연구에서는 녹농균의 carbapenem 내성기전을 분석하기 위해 OprD 및 유출펌프 조절유전자(MexR, NalC, NalD, MexT 및 MexZ)의 염색체상의 변이를 조사하였다. 아울러 quinolone 내성기전을 알아보기 위해 QRDR (quinolone resistance-determining region) 변이도 함께 조사하였다. 방법: Repetitive extragenic palindromic sequence-based PCR (rep-PCR)을 이용하여 서로 다른 클론에 속하는 녹농균을 선별하였다. 총 21주가 서로 밴드 패턴을 보였으며 이 균주들을 대상으로 PCR과 DNA 염기서열분석을 통해 β-lactamase 유전자를 검출하였고 유출펌프 조절유전자, oprD 및 QRDR (gyrA, gyrB, parC 및 parE)의 변이를 확인하였다. 결과: 분리된 21주의 녹농균 중 한 주(P28)가 blaVIM-2를 가지고 있었으며 2주가 nalD 또는 mexZ에 유출펌프의 과량발현을 유발할 수 있는 변이를 가지고 있었다. OprD의 소실을 유발할 수 있는 염색체상의 변이가 21주의 녹농균 중 4주에서확인되었다. Imipenem 및 ciprofloxacin에 내성인 녹농균 10주 중 9주가 gyrA와/또는 parC에 변이를 가지고 있었다. 결론: Carbapenem 내성 녹농균은 유출펌프의 과량발현, OprD 단백의 소실 및 carbapenemase 생성 등에 의해서 carbapenem에 내성을 나타낸다. 녹농균은 또한 gyrA와/또는 parC의 QRDR에 변이를 일으켜 quinolone에 내성을 나타낸다.
Abstract
Background: Outbreaks of carbapenem resistant P.aeruginosa give rise to significant therapeutic challenges for treating nosocomial infections. In this study, we analyzed carbapenem resistance mechanisms in carbapenem resistant and clonally different P. aeruginosa strains. We analyzed chromosomal alterations in the genes of OprD and efflux system regulatory proteins (MexR, NalC, NalD, MexT, and MexZ). We also investigated chromosomal alterations in the quinolone resistance-determining region (QRDR) for quinolone resistance mechanisms. Methods: Twenty-one clonally different P. aeruginosa strains were isolated by repetitive extragenic palindromic sequence-based PCR (rep-PCR). PCR and DNA sequencing were conducted for the detection of β-lactamase genes and chromosomal alterations of efflux pump regulatory genes, oprD, and QRDR in gyrA, gyrB, parC, and parE. Results: Only one (P28) of the 21 strains harbored blaVIM-2. Two isolates had mutations in nalD or mexZ that were associated with efflux pump overexpression. Chromosomal alterations causing loss of OprD were found in 4 out of 21 carbapenem resistant P. aeruginosa strains. Nine of 10 imipenem and ciprofloxacin resistant strains had alterations in gyrA and/or parC. Conclusion: Carbapenem resistance in P. aeruginosa was mediated by several mechanisms, including loss of the OprD, overexpression of efflux systems, and production of carbapenemase. Resistance to quinolone is frequently caused by point mutations in gyrA and/or parC.
참고문헌 (23)
- Jacoby GA, "More extended-spectrum beta-lactamases", Antimicrob Agents Chemother, 35, pp.1697~1704 (1991)
- 이경원, "Further Increase of Vancomycin-Resistant Enterococcus faecium, Amikacin- and Fluoroquinolone-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Acinetobacter spp. in Korea", Yonsei Medical Journal, 47(1), pp.43~54 (2006), 연세대학교의과대학
- Livermore DM, "Of Pseudomonas, porins, pumps and carbapenems", J Antimicrob Chemother, 47, pp.247~250 (2001)
- Edalucci E, "Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa", Clin Microbiol Infect, 14, pp.88~90 (2008)
- Pai H, "Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates", Antimicrob Agents Chemother, 45, pp.480~484 (2001)
- Köhler T, "Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa", Mol Microbiol, 23, pp.345~354 (1997)
- Sawada I, "A quorum-sensing autoinducer enhances the mexAB-oprM effluxpump expression without the MexR-mediated regulation in Pseudomonas aeruginosa", Microbiol Immunol, 48, pp.435~439 (2004)
- Quale J, "Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates", Antimicrob Agents Chemother, 50, pp.1633~1641 (2006)
- Sobel ML, "Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa", J Bacteriol, 187, pp.1246~1253 (2005)
- Vogne C, "Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis", Antimicrob Agents Chemother, 48, pp.1676~1680 (2004)
- 성지연, "Metallo-β-lactamase 생성 녹농균에서 Class 1 Integron의 유전형 분석", Annals of Clinical Microbiology, 12(1), pp.17~23 (2009), 대한임상미생물학회
- 윤외숙, "Imipenem 내성 Pseudomonas aeruginosa의 분리 현황과 내성 획득 기전", 대한임상미생물학회지, 8(1), pp.26~33 (2005), 대한임상미생물학회
- Jalal S, "Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa", Microb Drug Resist, 4, pp.257~261 (1998)
- Rubin J, "Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections", Vet Microbiol, 131, pp.164~172 (2008)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. M100-S10 (M2)", CLSI, ~
- Shannon KP, "Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000", J Antimicrob Chemother, 53, pp.818~825 (2004)
- 정선양, "Characteristics of Acquired β-lactamase Gene in Clinical Isolates of Multidrug-resistant Pseudomonas aeruginosa", 대한임상미생물학회지, 11(2), pp.98~106 (2008), 대한임상미생물학회
- Llanes C, "Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously", Antimicrob Agents Chemother, 48, pp.1797~1802 (2004)
- Ziha-Zarifi I, "In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM", Antimicrob Agents Chemother, 43, pp.287~291 (1999)
- Lee K, "Rapid increase of imipenemhydrolyzing Pseudomonas aeruginosa in a Korean hospital. Abstr E-85", ICAAC, ~ (1998)
- Lee K, "Korean Nationwide Surveillance of Antimicrobial Resistance Group. VIMand IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals", Emerg Infect Dis, 9, pp.868~871 (2003)
- Kim IS, "Increasing prevalence of imipenem-resistant Pseudomonas aeruginosa and molecular typing of metallo-beta-lactamase producers in a Korean hospital", Microb Drug Resist, 11, pp.355~359 (2005)
- Akasaka T, "Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance", Antimicrob Agents Chemother, 45, pp.2263~2268 (2001)
